GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » DHX Company Co Ltd (XKRX:031860) » Definitions » EBIT

DHX Company Co (XKRX:031860) EBIT : ₩-16,950 Mil (TTM As of Dec. 2024)


View and export this data going back to 1997. Start your Free Trial

What is DHX Company Co EBIT?

DHX Company Co's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2024 was ₩-11,141 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-16,950 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. DHX Company Co's annualized ROC % for the quarter that ended in Dec. 2024 was 11.37%. DHX Company Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -676.16%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. DHX Company Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -99.92%.


DHX Company Co EBIT Historical Data

The historical data trend for DHX Company Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DHX Company Co EBIT Chart

DHX Company Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11,673.17 -12,234.56 -11,457.44 -28,056.45 -16,949.55

DHX Company Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13,412.01 -3,278.97 1,168.63 -3,697.73 -11,141.48

Competitive Comparison of DHX Company Co's EBIT

For the Diagnostics & Research subindustry, DHX Company Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DHX Company Co's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, DHX Company Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where DHX Company Co's EV-to-EBIT falls into.


;
;

DHX Company Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-16,950 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DHX Company Co  (XKRX:031860) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

DHX Company Co's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2024 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=5671.596 * ( 1 - 0% )/( (56211.812 + 43580.349)/ 2 )
=5671.596/49896.0805
=11.37 %

where

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=60335.998 - 998.775 - ( 3125.411 - max(0, 2562.088 - 10144.884+3125.411))
=56211.812

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=56156.827 - 1883.991 - ( 10692.487 - max(0, 7815.595 - 21127.089+10692.487))
=43580.349

Note: The Operating Income data used here is four times the quarterly (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

DHX Company Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2024  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-44565.92/( ( (543.577 + max(2870.108, 0)) + (5238.014 + max(4530.386, 0)) )/ 2 )
=-44565.92/( ( 3413.685 + 9768.4 )/ 2 )
=-44565.92/6591.0425
=-676.16 %

where Working Capital is:

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2096.809 + 1491.908 + 1130.4) - (998.775 + 0 + 850.234)
=2870.108

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4168.847 + 1473.676 + 2044.138) - (1883.991 + 0 + 1272.284)
=4530.386

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

DHX Company Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2024 )
=-16949.549/16963.237
=-99.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DHX Company Co EBIT Related Terms

Thank you for viewing the detailed overview of DHX Company Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


DHX Company Co Business Description

Traded in Other Exchanges
N/A
Address
310 Bongeunsa-ro, 7th Floor, Gangnam-gu, Seoul, KOR, 135-080
DHX Company Co Ltd, formerly SU-Holdings Co Ltd is engaged in the development of devices to treat brain diseases based on low intensity focused ultrasound technology.

DHX Company Co Headlines

No Headlines